GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CRH Medical Corp (AMEX:CRHM) » Definitions » EPS without NRI

CRH Medical (CRH Medical) EPS without NRI : $-0.34 (TTM As of Dec. 2020)


View and export this data going back to 2008. Start your Free Trial

What is CRH Medical EPS without NRI?

CRH Medical's earnings per share without non-recurring items for the three months ended in Dec. 2020 was $-0.27. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.34.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for CRH Medical's EPS without NRI or its related term are showing as below:

CRHM's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.8
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

CRH Medical's EPS (Diluted) for the three months ended in Dec. 2020 was $-0.27. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.34.

CRH Medical's EPS (Basic) for the three months ended in Dec. 2020 was $-0.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.34.


CRH Medical EPS without NRI Historical Data

The historical data trend for CRH Medical's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRH Medical EPS without NRI Chart

CRH Medical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.16 0.06 0.05 -0.34

CRH Medical Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 -0.03 -0.04 -0.01 -0.27

Competitive Comparison of CRH Medical's EPS without NRI

For the Medical Instruments & Supplies subindustry, CRH Medical's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CRH Medical's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CRH Medical's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where CRH Medical's PE Ratio without NRI falls into.



CRH Medical EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CRH Medical  (AMEX:CRHM) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CRH Medical EPS without NRI Related Terms

Thank you for viewing the detailed overview of CRH Medical's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


CRH Medical (CRH Medical) Business Description

Traded in Other Exchanges
N/A
Address
999 Canada Place, Suite 578, World Trade Center, Vancouver, BC, CAN, V6C 3E1
CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Richard Bear officer: Chief Financial Officer 9062 NE 37TH PLACE, BELLEVUE WA 98004
Ian Webb director 7385 LABURNUM ST VANCOUVER A1 V6P 5N2
James Kreger officer: President 2580 ACORN AVE NE ATLANTA GA 30305
Tushar M Ramani director, officer: Chief Executive Officer 118 TALAVERA PLACE PALM BEACH GARDENS FL 33418
Brian T Griffin director
Todd Patrick director 9029 NE 36TH STREET, BELLEVUE WA 98004
David Allan Johnson director 7464 NORTH SHORE ROAD NORFOLK VA 23505
Anthony F Holler director 8855 NORTHBROOK CT BURNABY A1
Edward Wright officer: Chief Financial Officer 2992 WEST 31ST AVE VANCOUVER A1 V6L 2A4